Subscribe To
Novo nordisk weight loss drug wegovy cuts heart disease risk by 20%, trial shows
Novo Nordisk said the results of a late-stage drug trial showed weight loss drug Wegovy also can cut th...
August 8, 2023, 2:31 pm
Top ancillary cannabis stocks to watch in august: revolutionizing cannabis retail in the digital age
In a world that is quickly legalizing and normalizing cannabis, the industry's expansion is visible not just in the blossoming of cultivation and dist...
August 8, 2023, 2:00 pm
Eur/usd price analysis: further losses likely below 1.0912
EUR/USD extends the downward bias to new weekly lows near 1.0930 on Tuesday. Read Full Story at source (may require registration) The post EUR/USD Pri...
August 8, 2023, 1:59 pm
Weight-loss drug frenzy drives eli lilly and novo nordisk stock to record highs
Shares of Eli Lilly and Novo Nordisk both soared to record highs on Tuesday, as sales increased of Eli Lilly's Mounjaro and as Novo Nordisk reports a ...
August 8, 2023, 1:51 pm
Nasdaq: ptra lawsuit notice: investors who lost over $100,000 with shares of proterra inc. (nasdaq: ptra) should contact the shareholders foundation
SAN DIEGO, Aug. 08, 2023 (GLOBE NEWSWIRE) — The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Proterra I...
August 8, 2023, 1:49 pm
Novo nordisk adrs surge after wegovy shown to reduce heart attack, stroke risks
ADRs of Novo Nordisk surged to an all-time high after a study found Novo Nordisk's Wegovy weight-loss drug also helped cut risk of major adverse cardi...
August 8, 2023, 12:56 pm
Braemar hotels & resorts: bad q2, even worse balance sheet
Braemar Hotels & Resorts reported a net loss of $13 million in Q2 2023, with a decline in revenue per a...
August 8, 2023, 12:16 pm
Gbp/usd: demand on weakness to or just below 1.27 should help limit losses in the near term – scotiabank
Spot looks soft on the short-term chart but the intraday and daily patterns reflect firm demand for the Pound on weakness to or just below 1.27 late l...
August 8, 2023, 12:14 pm
Eur/usd looks soft but scope for losses should remain relatively limited – scotiabank
EUR/USD eases back to the mid-1.09 area. Economists at Scotiabank analyze the pair’s outlook. The EUR looks soft but scope for...
August 8, 2023, 12:14 pm
Wideopenwest (wow) reports q2 loss, lags revenue estimates
WideOpenWest (WOW) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimat...
August 8, 2023, 12:10 pm
Pra group (praa) q2 loss relieved by lower operating costs
PRA Group (PRAA) expects compensation expenses to be in the mid-$70 million range in the third quarter....
August 8, 2023, 12:10 pm
Why eli lilly, novo nordisk, and viking therapeutics are on fire today
Novo Nordisk's popular weight loss drug significantly reduced the risk of heart attack or stroke in a l...
August 8, 2023, 11:45 am
Sealed air corp (see): an undervalued gem in the packaging industry?
Despite a daily loss of 7.91% and a 3-month loss of 6.43...
August 8, 2023, 11:37 am
Eur/sek: krona to rebound further from undervalued levels – mufg
The Krona has staged a strong rebound in July which marks an abrupt reversal of losses sustained during...
August 8, 2023, 11:29 am
Mersana therapeutics, inc. (mrsn) reports q2 loss, misses revenue estimates
Mersana Therapeutics, Inc. (MRSN) came out with a quarterly loss of $0.47 per share versus the Zacks Co...
August 8, 2023, 11:25 am
Recursion pharmaceuticals (rxrx) reports q2 loss, tops revenue estimates
Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.38 per share in line with the Zac...
August 8, 2023, 11:25 am
Theravance's (tbph) q2 earnings beat estimates, revenues miss
Thervance's (TBPH) second-quarter 2023 loss is narrower than expected. Revenues rise year over year....
August 8, 2023, 11:25 am
Usd/chf and eur/chf could bounce as status quo by the snb would take the gloss off the franc – socgen
No further rate increase in September and ‘higher for longer’ policy outlooks at the Fed and ECB, even without further hikes, could precipitate a ...
August 8, 2023, 10:59 am
Arvinas, inc. (arvn) reports q2 loss, tops revenue estimates
Arvinas, Inc. (ARVN) came out with a quarterly loss of $1.25 per share versus the Zacks Consensus Estim...
August 8, 2023, 10:40 am
Syros pharmaceuticals, inc. (syrs) reports q2 loss, lags revenue estimates
Syros Pharmaceuticals, Inc. (SYRS) came out with a quarterly loss of $1.30 per share versus the Zacks C...
August 8, 2023, 10:40 am